Download PDF
copy of the manuscript
Published
online 6 August 2010 Nucleic Acids Research, 2010, Vol. 38, No. 19 e180
doi:10.1093/nar/gkq677
Alex Y. Borovkov1,*, Andrey V. Loskutov1, Mark D. Robida1, Kristen M. Day1, Jose A. Cano1, Tien Le Olson1, Hetal Patel1, Kevin Brown1, Preston D. Hunter1 and Kathryn F. Sykes1,2,
1Center
for Innovations in Medicine of the Biodesign Institute at the Arizona State
University, Tempe, AZ 85287 and 2School of Life Sciences,
Arizona State University, Tempe, AZ 85287, USA
Received
March 23, 2010; Revised July 19, 2010; Accepted July 21, 2010
ABSTRACT
To
meet
the
growing
demand
for
synthetic
genes
more
robust,
scalable
and
inexpensive
gene
assembly
technologies must
be
developed.
Here,
we
present
a protocol
for
high-quality gene
assembly
directly
from
low-cost
marginal-quality microarray-synthesized oligonucleotides. Significantly, we eliminated the time-and money-consuming oligonucleotide purification steps through the use of hybridization-based selection embedded in the assembly process. The protocol was tested on mixtures of up to 2000 oligonucleotides eluted directly from microarrays obtained from three different chip manufacturers. These mixtures containing <5% perfect oligos, and were used directly for assembly of 27 test genes of different sizes. Gene quality was assessed by sequencing, and their activity was tested in coupled in vitro transcription/ translation reactions. Genes assembled from the microarray-eluted material using the new protocol matched the quality of the genes assembled from >95% pure column-synthesized oligonucleotides by the standard protocol. Both averaged only 2.7
errors/kb, and genes assembled from microarray-eluted material without clonal
selection produced only 30% less protein than sequence-confirmed clones. This
report represents the first demonstration of cost-efficient gene assembly from
microarray-synthesized oligonucleotides. The overall cost of assembly by this
method approaches 5¢ per base, making gene synthesis more affordable than
traditional cloning.
*To whom correspondence should be addressed. Tel: +1 469 774 2263; Email: aborovkov@synbuild.com
Present
addresses:
Alex Y. Borovkov, Synbuild LLC,
1833 W. Main Street, Suite 129, Mesa, AZ 85201, USA.
Jose A. Cano and Tien Le Olson,
Departmento de Biotecnologia, Psicofarma, Mexico City, Mexico 14050, USA.
Hetal Patel, Kevin Brown and Preston D. Hunter, Covance Laboratories Inc., Chandler, AZ 85249, USA.
� The Author(s) 2010. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.